Dr. Ahmad Tarhini, MD, PhD
Claim this profileMoffitt Cancer Center
Expert in Melanoma
Studies Skin Cancer
19 reported clinical trials
30 drugs studied
About Ahmad Tarhini, MD, PhD
Education:
- MD from the American University of Beirut, Lebanon (2005).
- PhD in Clinical Investigation from the University of South Florida (2012).
Experience:
- Senior Member at Moffitt Cancer Center.
- Associate Center Director for Clinical Research.
- Chair of the Department of Gastrointestinal Oncology.
- Professor of Oncologic Sciences at the University of South Florida Morsani College of Medicine.
Area of expertise
1Melanoma
Global LeaderStage IV
Stage III
BRAF positive
2Skin Cancer
Stage IV
Stage III
Stage II
Affiliated Hospitals
Clinical Trials Ahmad Tarhini, MD, PhD is currently running
IL2 + Ipilimumab and Nivolumab
for Melanoma
The purpose of this study is to find out if the administration of Interleukin-2 concurrently with ipilimumab followed by Nivolumab will result in improved anti-cancer activity and if it is effective for advanced melanoma.
Recruiting1 award Phase 213 criteria
Encorafenib + Binimetinib
for Melanoma
The purpose of this study is to assess rate of disease relapse and hazard rate of disease relapse after neoadjuvant therapy based on the statuses of pathologic complete response or non-pathologic complete response, and postoperative adjuvant therapy.
Recruiting1 award Phase < 17 criteria
More about Ahmad Tarhini, MD, PhD
Clinical Trial Related5 years of experience running clinical trials · Led 19 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments Ahmad Tarhini, MD, PhD has experience with
- Nivolumab
- Ipilimumab
- Binimetinib
- Pembrolizumab
- Belinostat
- Interleukin-2
Breakdown of trials Ahmad Tarhini, MD, PhD has run
Melanoma
Skin Cancer
Merkel Cell Carcinoma
Eye Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ahmad Tarhini, MD, PhD specialize in?
Ahmad Tarhini, MD, PhD focuses on Melanoma and Skin Cancer. In particular, much of their work with Melanoma has involved Stage IV patients, or patients who are Stage III.
Is Ahmad Tarhini, MD, PhD currently recruiting for clinical trials?
Yes, Ahmad Tarhini, MD, PhD is currently recruiting for 9 clinical trials in Tampa Florida. If you're interested in participating, you should apply.
Are there any treatments that Ahmad Tarhini, MD, PhD has studied deeply?
Yes, Ahmad Tarhini, MD, PhD has studied treatments such as Nivolumab, Ipilimumab, Binimetinib.
What is the best way to schedule an appointment with Ahmad Tarhini, MD, PhD?
Apply for one of the trials that Ahmad Tarhini, MD, PhD is conducting.
What is the office address of Ahmad Tarhini, MD, PhD?
The office of Ahmad Tarhini, MD, PhD is located at: Moffitt Cancer Center, Tampa, Florida 33612 United States. This is the address for their practice at the Moffitt Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.